Amgen director receives 665-share stock award
Klotman Mary E. reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Klotman Mary E. reported acquisition or exercise transactions in this Form 4 filing.
Amgen director Mary E. Klotman received an equity award of 665 shares of common stock in the form of Restricted Stock Units. The RSUs were granted under Amgen’s 2009 Director Incentive Program and vested immediately, paying out in common shares on a one-to-one basis.
Following this grant, Klotman directly holds 2,211 shares of Amgen common stock, which include 18 dividend-equivalent units credited to her unvested RSUs under the company’s equity incentive plan.
Insider Trade Summary
Grant/Award: 665 shares
Grant/Award
1 txn
Insider
Klotman Mary E.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 665 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 2,211 shares (Direct)
Footnotes (2)
- F1. The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.
- F2. These shares include 18 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Key Figures
RSU grant size: 665 shares
Holdings after grant: 2,211 shares
Dividend equivalents: 18 DEs
3 metrics
RSU grant size
665 shares
Common Stock RSUs granted to director on May 19, 2026
Holdings after grant
2,211 shares
Total Amgen common shares directly owned after the transaction
Dividend equivalents
18 DEs
Dividend equivalents credited to unvested RSUs, payable in shares
Key Terms
Restricted Stock Units (RSUs), Director Incentive Program, Equity Incentive Plan, Dividend equivalents (DEs), +1 more
5 terms
Restricted Stock Units (RSUs) financial
"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Director Incentive Program financial
"granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended"
Equity Incentive Plan financial
"under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Dividend equivalents (DEs) financial
"These shares include 18 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
deferral schedule financial
"Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Amgen (AMGN) director Mary E. Klotman receive in this Form 4 filing?
Mary E. Klotman received an equity award of 665 Amgen common shares via Restricted Stock Units. These RSUs were granted under Amgen’s 2009 Director Incentive Program and vested immediately, paying out in shares of common stock on a one-to-one basis.
What are the terms of the Restricted Stock Units granted to Amgen (AMGN) director Klotman?
The RSUs granted to Klotman vested immediately and are paid in Amgen common stock on a one-to-one basis. Vested RSUs may also be deferred at her election, with share delivery occurring later according to the chosen deferral schedule under the plan.
How are dividend equivalents (DEs) treated in Amgen (AMGN) director RSU awards?
Dividend equivalents are credited to the director’s unvested RSUs and track dividends on Amgen stock. For Klotman, 18 DEs are included and will be paid in common stock on a one-to-one basis as the related RSUs vest, plus cash for any fractional amount.
Was Mary E. Klotman’s Amgen (AMGN) Form 4 transaction an open-market stock purchase?
No, the transaction was a grant or award acquisition of 665 shares through Restricted Stock Units, not an open-market purchase. The RSUs were issued as director compensation under Amgen’s 2009 Director Incentive Program and vested immediately into common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
